Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019
In this report, the global metabolic testing market is segmented on the basis of products, technologies, applications, end users, and regions. The product segments of the market included in the report are CPET systems, metabolic carts, ECGs and EKGs, body composition analyzers, and software. The technology segments of the market included in the report are VO2 max analysis, RMR analysis, and body composition analysis. The application segments of the market included in the report are lifestyle diseases, critical care, human performance testing, dysmetabolic syndrome X, metabolic disorders, and other applications. The end-user segments of the market included in the report are hospitals, laboratories, sports training centers, gyms, and other end users. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).
Rising prevalence of lifestyle diseases are the primary drivers for this market. Market growth will also be aided by technological advancements and increasing healthcare expenditure.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global metabolic testing market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of the metabolic testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth. The report includes company profiles and a competitive landscape of the metabolic testing market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analysis of industry developments such as acquisitions, agreements and partnerships, and new product launches.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
Rising prevalence of lifestyle diseases are the primary drivers for this market. Market growth will also be aided by technological advancements and increasing healthcare expenditure.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global metabolic testing market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of the metabolic testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth. The report includes company profiles and a competitive landscape of the metabolic testing market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analysis of industry developments such as acquisitions, agreements and partnerships, and new product launches.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
- Product Development: Product portfolios of the top players in the metabolic testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the metabolic testing market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the metabolic testing market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various metabolic testing equipment and software across geographies
1 INTRODUCTION
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 Metabolic Testing Market to Experience Significant Growth
4.2 Life Cycle Analysis, By Region
5 MARKET OVERVIEW
5.1 Introduction
5.2 Market Segmentation
5.2.1 Metabolic Testing Market, By Product
5.2.2 Market, By Application
5.2.3 Market, By Test
5.2.4 Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Healthcare Expenditure
5.3.1.2 Rising Incidence of Lifestyle Diseases
5.3.1.3 Technological Advancements
5.3.2 Restraints
5.3.2.1 High Cost of Equipment and Software
5.3.2.2 Reimbursement Issues
5.3.3 Opportunities
5.3.3.1 Emerging Economies
6 INDUSTRY INSIGHTS
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Intensity of Rivalry
6.3 Strategic Benchmarking
6.4 Supply Chain Analysis
6.4.1 Key Influencer
7 METABOLIC TESTING MARKET, BY PRODUCT
7.1 Introduction
7.2 CPET Systems
7.3 Metabolic Carts
7.4 ECG and EKG Systems
7.5 Body Composition Analyzers
7.6 Software
8 METABOLIC TESTING MARKET, BY APPLICATION
8.1 Introduction
8.2 Lifestyle Diseases
8.3 Critical Care
8.4 Human Performance Testing
8.5 Dysmetabolic Syndrome X
8.6 Metabolic Disorders
8.7 Other Applications
9 METABOLIC TESTING MARKET, BY TECHNOLOGY
9.1 Introduction
9.2 VO2 Max Analysis
9.3 RMR Analysis
9.4 Body Composition Analysis
10 METABOLIC TESTING MARKET, BY END USER
10.1 Introduction
10.2 Hospitals
10.3 Laboratories
10.4 Sports Training Centers
10.5 GYMS
10.6 Other End Users
11 GEOGRAPHIC ANALYSIS
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia
11.5 Rest of the World
12 COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Leading Players in the Metabolic Testing Market
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Agreements and Partnerships
12.3.3 Acquisitions
12.3.4 Expansions
12.3.5 Other Developments
13 COMPANY PROFILES
13.1 Introduction
13.2 Carefusion Corporation
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Recent Developments
13.2.4 MNM View
13.2.4.1 Financial Analysis
13.2.4.2 Strategic Analysis
13.3 General Electric Company
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Recent Developments
13.3.4 MNM View
13.3.4.1 Financial Analysis
13.4 Geratherm Medical AG
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Recent Developments
13.4.4 MNM View
13.4.4.1 Financial Analysis
13.5 MGC Diagnostics Corporation
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Recent Developments
13.5.4 MNM View
13.5.4.1 Financial Analysis
13.5.4.2 Strategic Analysis
13.6 OSI Systems, Inc.
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Recent Developments
13.6.4 MNM View
13.6.4.1 Financial Analysis
13.6.4.2 Strategic Analysis
13.7 AEI Technologies, Inc.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Recent Developments
13.7.4 Key Strategy
13.8 Cortex Biophysik GMBH
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Recent Developments
13.8.4 Key Strategy
13.9 Cosmed
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Recent Developments
13.9.4 Key Strategy
13.1 Korr Medical Technologies, Inc.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Recent Developments
13.10.4 Key Strategy
13.11 Microlife Medical Home Solutions, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Recent Developments
13.11.4 Key Strategy
13.12 Parvo Medics
13.12.1 Business Overview
13.12.2 Product Portfolio
13.12.3 Recent Developments
13.12.4 Key Strategy
14 APPENDIX
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 Metabolic Testing Market to Experience Significant Growth
4.2 Life Cycle Analysis, By Region
5 MARKET OVERVIEW
5.1 Introduction
5.2 Market Segmentation
5.2.1 Metabolic Testing Market, By Product
5.2.2 Market, By Application
5.2.3 Market, By Test
5.2.4 Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Healthcare Expenditure
5.3.1.2 Rising Incidence of Lifestyle Diseases
5.3.1.3 Technological Advancements
5.3.2 Restraints
5.3.2.1 High Cost of Equipment and Software
5.3.2.2 Reimbursement Issues
5.3.3 Opportunities
5.3.3.1 Emerging Economies
6 INDUSTRY INSIGHTS
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Intensity of Rivalry
6.3 Strategic Benchmarking
6.4 Supply Chain Analysis
6.4.1 Key Influencer
7 METABOLIC TESTING MARKET, BY PRODUCT
7.1 Introduction
7.2 CPET Systems
7.3 Metabolic Carts
7.4 ECG and EKG Systems
7.5 Body Composition Analyzers
7.6 Software
8 METABOLIC TESTING MARKET, BY APPLICATION
8.1 Introduction
8.2 Lifestyle Diseases
8.3 Critical Care
8.4 Human Performance Testing
8.5 Dysmetabolic Syndrome X
8.6 Metabolic Disorders
8.7 Other Applications
9 METABOLIC TESTING MARKET, BY TECHNOLOGY
9.1 Introduction
9.2 VO2 Max Analysis
9.3 RMR Analysis
9.4 Body Composition Analysis
10 METABOLIC TESTING MARKET, BY END USER
10.1 Introduction
10.2 Hospitals
10.3 Laboratories
10.4 Sports Training Centers
10.5 GYMS
10.6 Other End Users
11 GEOGRAPHIC ANALYSIS
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia
11.5 Rest of the World
12 COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Leading Players in the Metabolic Testing Market
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Agreements and Partnerships
12.3.3 Acquisitions
12.3.4 Expansions
12.3.5 Other Developments
13 COMPANY PROFILES
13.1 Introduction
13.2 Carefusion Corporation
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Recent Developments
13.2.4 MNM View
13.2.4.1 Financial Analysis
13.2.4.2 Strategic Analysis
13.3 General Electric Company
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Recent Developments
13.3.4 MNM View
13.3.4.1 Financial Analysis
13.4 Geratherm Medical AG
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Recent Developments
13.4.4 MNM View
13.4.4.1 Financial Analysis
13.5 MGC Diagnostics Corporation
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Recent Developments
13.5.4 MNM View
13.5.4.1 Financial Analysis
13.5.4.2 Strategic Analysis
13.6 OSI Systems, Inc.
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Recent Developments
13.6.4 MNM View
13.6.4.1 Financial Analysis
13.6.4.2 Strategic Analysis
13.7 AEI Technologies, Inc.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Recent Developments
13.7.4 Key Strategy
13.8 Cortex Biophysik GMBH
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Recent Developments
13.8.4 Key Strategy
13.9 Cosmed
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Recent Developments
13.9.4 Key Strategy
13.1 Korr Medical Technologies, Inc.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Recent Developments
13.10.4 Key Strategy
13.11 Microlife Medical Home Solutions, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Recent Developments
13.11.4 Key Strategy
13.12 Parvo Medics
13.12.1 Business Overview
13.12.2 Product Portfolio
13.12.3 Recent Developments
13.12.4 Key Strategy
14 APPENDIX
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports
LIST OF TABLES
Table 1 Metabolic Testing Market Summary
Table 2 Market Developments Between 2010 and 2014
Table 3 Global Metabolic Testing Market Size, By Product, 2012–2019 ($Million)
Table 4 Market Size for CPET Systems, By Region, 2012-2019 ($Million)
Table 5 Market Size for CPET Systems, By Type, 2012-2019 ($Million)
Table 6 Metabolic Carts Market Size, By Region, 2012-2019 ($Million)
Table 7 Metabolic Carts Market Size, By Type, 2012-2019 ($Million)
Table 8 Market Size for ECG and EKG Systems, By Region, 2012-2019 ($Million)
Table 9 Market Size for ECG and EKG Systems, By Type, 2012-2019 ($Million)
Table 10 Market Size for Body Composition Analyzers, By Region, 2012-2019 ($Million)
Table 11 Market Size for Body Composition Analyzers, By Type, 2012-2019 ($Million)
Table 12 Market Size for Software, By Region, 2012-2019 ($Million)
Table 13 Market Size, By Application, 2012–2019 ($Million)
Table 14 Market Size for Lifestyle Diseases, By Region, 2012–2019 ($Million)
Table 15 Market Size for Critical Care, By Region, 2012–2019 ($Million)
Table 16 Market Size for Human Performance Testing, By Region, 2012–2019 ($Million)
Table 17 Market Size for Dysmetabolic Syndrome X , By Region, 2012–2019 ($Million)
Table 18 Market Size for Metabolic Disorders, By Region, 2012–2019 ($Million)
Table 19 Market Size for Other Applications, By Region, 2012–2019 ($Million)
Table 20 Market Size, By Technology, 2012–2019 ($Million)
Table 21 VO2 Max Analysis Market Size, By Region, 2012–2019 ($Million)
Table 22 RMR Analysis Market Size, By Region, 2012–2019 ($Million)
Table 23 Body Composition Analysis Market Size, By Region, 2012–2019 ($Million)
Table 24 Market Size, By End User, 2012–2019 ($Million)
Table 25 Market Size for Hospitals, By Region, 2012–2019 ($Million)
Table 26 Market Size for Laboratories, By Region, 2012–2019 ($Million)
Table 27 Market Size for Sports Training Centers, By Region, 2012–2019 ($Million)
Table 28 Market Size for GYMS, By Region, 2012–2019 ($Million)
Table 29 Market Size for Other End Users, By Region, 2012–2019 ($Million)
Table 30 Market, By Region, 2012–2019 ($Million)
Table 31 North America: Market Size, By Product, 2012–2019 ($Million)
Table 32 North America: CPET Systems Market, By Type, 2012–2019 ($Million)
Table 33 North America: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 34 North America: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 35 North America: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 36 North America: Market, By Application, 2012–2019 ($Million)
Table 37 North America: Market, By Technology, 2012–2019 ($Million)
Table 38 North America: Market, By End User, 2012–2019 ($Million)
Table 39 Europe: Market, By Products, 2012–2019 ($Million)
Table 40 Europe: CPET Systems Market, By Type, 2012–2019 ($Million))
Table 41 Europe: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 42 Europe: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 43 Europe: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 44 Europe: Market, By Application, 2012–2019 ($Million)
Table 45 Europe: Market, By Technology, 2012–2019 ($Million)
Table 46 Europe: Market, By End User, 2012–2019 ($Million)
Table 47 Asia: Market, By Product, 2012–2019 ($Million)
Table 48 Asia: CPET Systems Market, By Type, 2012–2019 ($Million))
Table 49 Asia: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 50 Asia: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 51 Asia: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 52 Asia: Metabolic Testing Market, By Application, 2012–2019 ($Million)
Table 53 Asia: Metabolic Testing Market, By Technology, 2012–2019 ($Million)
Table 54 Asia: Metabolic Testing Market, By End User, 2012–2019 ($Million)
Table 55 ROW: Market, By Product, 2012–2019 ($Million)
Table 56 ROW: CPET Systems Market, By Type, 2012–2019 ($Million)
Table 57 ROW: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 58 ROW: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 59 ROW: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 60 ROW: Metabolic Testing Market, By Application, 2012–2019 ($Million)
Table 61 ROW: Metabolic Testing Market, By Technology, 2012–2019 ($Million)
Table 62 ROW: Metabolic Testing Market, By End User, 2012–2019 ($Million)
Table 63 Rank of Companies in the Global Metabolic Testing Market
Table 64 New Product Launches, 2011–2014
Table 65 Agreements and Partnerships, 2011–2014
Table 66 Acquisitions, 2011–2014
Table 67 Expansions, 2011–2014
Table 68 Other Developments, 2011–2014
Table 1 Metabolic Testing Market Summary
Table 2 Market Developments Between 2010 and 2014
Table 3 Global Metabolic Testing Market Size, By Product, 2012–2019 ($Million)
Table 4 Market Size for CPET Systems, By Region, 2012-2019 ($Million)
Table 5 Market Size for CPET Systems, By Type, 2012-2019 ($Million)
Table 6 Metabolic Carts Market Size, By Region, 2012-2019 ($Million)
Table 7 Metabolic Carts Market Size, By Type, 2012-2019 ($Million)
Table 8 Market Size for ECG and EKG Systems, By Region, 2012-2019 ($Million)
Table 9 Market Size for ECG and EKG Systems, By Type, 2012-2019 ($Million)
Table 10 Market Size for Body Composition Analyzers, By Region, 2012-2019 ($Million)
Table 11 Market Size for Body Composition Analyzers, By Type, 2012-2019 ($Million)
Table 12 Market Size for Software, By Region, 2012-2019 ($Million)
Table 13 Market Size, By Application, 2012–2019 ($Million)
Table 14 Market Size for Lifestyle Diseases, By Region, 2012–2019 ($Million)
Table 15 Market Size for Critical Care, By Region, 2012–2019 ($Million)
Table 16 Market Size for Human Performance Testing, By Region, 2012–2019 ($Million)
Table 17 Market Size for Dysmetabolic Syndrome X , By Region, 2012–2019 ($Million)
Table 18 Market Size for Metabolic Disorders, By Region, 2012–2019 ($Million)
Table 19 Market Size for Other Applications, By Region, 2012–2019 ($Million)
Table 20 Market Size, By Technology, 2012–2019 ($Million)
Table 21 VO2 Max Analysis Market Size, By Region, 2012–2019 ($Million)
Table 22 RMR Analysis Market Size, By Region, 2012–2019 ($Million)
Table 23 Body Composition Analysis Market Size, By Region, 2012–2019 ($Million)
Table 24 Market Size, By End User, 2012–2019 ($Million)
Table 25 Market Size for Hospitals, By Region, 2012–2019 ($Million)
Table 26 Market Size for Laboratories, By Region, 2012–2019 ($Million)
Table 27 Market Size for Sports Training Centers, By Region, 2012–2019 ($Million)
Table 28 Market Size for GYMS, By Region, 2012–2019 ($Million)
Table 29 Market Size for Other End Users, By Region, 2012–2019 ($Million)
Table 30 Market, By Region, 2012–2019 ($Million)
Table 31 North America: Market Size, By Product, 2012–2019 ($Million)
Table 32 North America: CPET Systems Market, By Type, 2012–2019 ($Million)
Table 33 North America: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 34 North America: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 35 North America: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 36 North America: Market, By Application, 2012–2019 ($Million)
Table 37 North America: Market, By Technology, 2012–2019 ($Million)
Table 38 North America: Market, By End User, 2012–2019 ($Million)
Table 39 Europe: Market, By Products, 2012–2019 ($Million)
Table 40 Europe: CPET Systems Market, By Type, 2012–2019 ($Million))
Table 41 Europe: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 42 Europe: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 43 Europe: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 44 Europe: Market, By Application, 2012–2019 ($Million)
Table 45 Europe: Market, By Technology, 2012–2019 ($Million)
Table 46 Europe: Market, By End User, 2012–2019 ($Million)
Table 47 Asia: Market, By Product, 2012–2019 ($Million)
Table 48 Asia: CPET Systems Market, By Type, 2012–2019 ($Million))
Table 49 Asia: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 50 Asia: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 51 Asia: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 52 Asia: Metabolic Testing Market, By Application, 2012–2019 ($Million)
Table 53 Asia: Metabolic Testing Market, By Technology, 2012–2019 ($Million)
Table 54 Asia: Metabolic Testing Market, By End User, 2012–2019 ($Million)
Table 55 ROW: Market, By Product, 2012–2019 ($Million)
Table 56 ROW: CPET Systems Market, By Type, 2012–2019 ($Million)
Table 57 ROW: Metabolic Carts Market, By Type, 2012–2019 ($Million)
Table 58 ROW: ECG and EKG Systems Market, By Type, 2012–2019 ($Million)
Table 59 ROW: Body Composition Analyzers Market, By Type, 2012–2019 ($Million)
Table 60 ROW: Metabolic Testing Market, By Application, 2012–2019 ($Million)
Table 61 ROW: Metabolic Testing Market, By Technology, 2012–2019 ($Million)
Table 62 ROW: Metabolic Testing Market, By End User, 2012–2019 ($Million)
Table 63 Rank of Companies in the Global Metabolic Testing Market
Table 64 New Product Launches, 2011–2014
Table 65 Agreements and Partnerships, 2011–2014
Table 66 Acquisitions, 2011–2014
Table 67 Expansions, 2011–2014
Table 68 Other Developments, 2011–2014
According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 billion in 2003 to $7,163.64 billion in 2012, at a CAGR of 7.39%. During this period, the public healthcare spending increased at a CAGR of 7.82%, from $2,182.47 billion in 2003 to $4,285.10 billion in 2012. On the other hand, the global population increased at a CAGR of 1.19%, from 6,302 million in 2003 to 7,008 million in 2012. The per capita healthcare spending also increased from $598 in 2003 to $1,022 in 2012, at a CAGR of 6.13%. Increase in healthcare expenditure is an important growth driver for the metabolic testing market.
The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% from 2014 to 2019.
Major players of Metabolic Testing Market market are
- CareFusion Corporation (U.S.)
- MGC Diagnostics Corporation (U.S.)
- General Electric Company (U.S.)
- OSI Systems, Inc. (U.S.)
- KORR Medical Technologies, Inc. (U.S.)
Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement may hinder the growth of this market.
The global metabolic testing market is segmented on the basis of products, technologies, and applications. CPET system was the largest product segment while VO2 max analysis was the largest technology segment in 2014. VO2 max assessment is an important parameter for metabolic testing and is one of the most widely prescribed metabolic tests for athletes, healthy individuals, as well as patients. The lifestyle diseases application segment accounted for the largest share of the global metabolic testing market owing to the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity.
